The paper seeks to provide a detailed analysis of current patent strategies for companies involved in personalized medicine and the potential consequences for individuals’ rights protection. It thus outlines the legal, ethical and moral issues generated by the indiscriminate issuing of patents on human DNA sequences addressing the potential implications of diagnostic gene patents for access to health care. In particular the manuscript analyses current international court cases on gene and method patents and their significance for the future of personalized medicine, diagnostics methods and access to patented medicine. The paper concludes with a brief analysis of policy considerations for whole genome sequencing and suggestions for a more balanced set of rules that support public interest values.
LA TUTELA BREVETTUALE DEL PATRIMONIO GENETICO TRA SCIENZE MEDICHE E DIRITTI DELLA PERSONA
LUCCHI, Nicola
2013
Abstract
The paper seeks to provide a detailed analysis of current patent strategies for companies involved in personalized medicine and the potential consequences for individuals’ rights protection. It thus outlines the legal, ethical and moral issues generated by the indiscriminate issuing of patents on human DNA sequences addressing the potential implications of diagnostic gene patents for access to health care. In particular the manuscript analyses current international court cases on gene and method patents and their significance for the future of personalized medicine, diagnostics methods and access to patented medicine. The paper concludes with a brief analysis of policy considerations for whole genome sequencing and suggestions for a more balanced set of rules that support public interest values.I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
